Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor

Front Immunol. 2024 Feb 27:15:1323406. doi: 10.3389/fimmu.2024.1323406. eCollection 2024.

Abstract

Both viral infection and vaccination affect the antibody repertoire of a person. Here, we demonstrate that the analysis of serum antibodies generates information not only on the virus type that caused the infection but also on the specific virus variant. We developed a rapid multiplex assay providing a fingerprint of serum antibodies against five different SARS-CoV-2 variants based on a microarray of virus antigens immobilized on the surface of a label-free reflectometric biosensor. We analyzed serum from the plasma of convalescent subjects and vaccinated volunteers and extracted individual antibody profiles of both total immunoglobulin Ig and IgA fractions. We found that Ig level profiles were strongly correlated with the specific variant of infection or vaccination and that vaccinated subjects displayed a larger quantity of total Ig and a lower fraction of IgA relative to the population of convalescent unvaccinated subjects.

Keywords: IgA; antibody repertoire; immunoglobulins; label-free biosensor; rapid detection; reflective phantom interface; serological assay; wash-free assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Immunoglobulin A
  • Immunoglobulins
  • SARS-CoV-2*

Substances

  • Immunoglobulins
  • Immunoglobulin A

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has received funding from Ministero dell’Università e della Ricerca through grants: CN00000041 “National Center for Gene Therapy and Drugs based on RNA Technology” (CUP G43C22001320007, PNRR MUR-M4C2-Investimento 1.4, funded by European Union—NextGenerationEU); FISR 2020 COVID, “VIAEREA” project No. FISR2020IP-04633; PRIN 2017, project No. 2017Z55KCW; “Erogazione liberale per le attività di ricerca sul Coronavirus”, No. LIBVT20COVID19SEPIS; and Fondazione “Romeo ed Enrica Invernizzi” No. LIBVT21BAND. LC and TI were supported by young scientist fellowships from the UNIMI GSA-IDEA project. The authors acknowledge support from the University of Milan through the APC initiative.